oltipraz has been researched along with Hepatitis B in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, SH; Choi, JY; Chon, CY; Han, JY; Jang, JJ; Jang, JW; Kim, SG; Kim, YM; Lee, DH; Lee, YS; Um, SH; Yu, E | 1 |
| Groopman, JD; Kensler, TW | 1 |
| Chen, B; Davidson, NE; Egner, PA; Enger, C; Fang, X; Gordon, GB; Gorman, MB; Groopman, JD; Helzlsouer, KJ; Jacobson, LP; Kensler, TW; Kuang, SY; Li, YF; Muñoz, A; Prochaska, HJ; Qian, GS; Wang, JB; Wu, Y; Yu, LY; Zarba, A; Zhang, BC; Zhang, QN; Zhu, YR | 1 |
| Alaoui-Jamali, MA; Batist, G; Fotouhi-Ardakani, N; Jaitovitch-Groisman, I; Schecter, RL; Woo, A | 1 |
1 review(s) available for oltipraz and Hepatitis B
| Article | Year |
|---|---|
Carcinogen-DNA and protein adducts: biomarkers for cohort selection and modifiable endpoints in chemoprevention trials.
Topics: Aflatoxin B1; Aflatoxins; Aged; Anticarcinogenic Agents; Biomarkers, Tumor; Carcinogens; Clinical Trials as Topic; Cohort Studies; DNA Adducts; Guanine; Hepatitis B; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Proteins; Pyrazines; Risk Factors; Thiones; Thiophenes | 1996 |
2 trial(s) available for oltipraz and Hepatitis B
| Article | Year |
|---|---|
Oltipraz therapy in patients with liver fibrosis or cirrhosis: a randomized, double-blind, placebo-controlled phase II trial.
Topics: Adult; Anticarcinogenic Agents; Biomarkers; Biopsy; Collagen; Double-Blind Method; Female; Hepatitis B; Hepatitis C; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Pyrazines; Thiones; Thiophenes; Transforming Growth Factor beta1 | 2011 |
Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes.
Topics: Adult; Aflatoxins; Aged; Anticarcinogenic Agents; Carcinoma, Hepatocellular; China; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Hepatitis B; Humans; Liver Neoplasms; Male; Middle Aged; Pyrazines; Thiones; Thiophenes | 1997 |
1 other study(ies) available for oltipraz and Hepatitis B
| Article | Year |
|---|---|
Modulation of glutathione S-transferase alpha by hepatitis B virus and the chemopreventive drug oltipraz.
Topics: Antiviral Agents; Gene Expression Regulation, Enzymologic; Glutathione Transferase; Hepatitis B; Hepatitis B virus; Humans; Isoenzymes; Promoter Regions, Genetic; Pyrazines; RNA, Messenger; Sp1 Transcription Factor; Thiones; Thiophenes; Trans-Activators; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Viral Regulatory and Accessory Proteins | 2000 |